Aria F Olumi MD

Chief of Urologic Surgery at Beth Israel Deaconess Medical Center / Janet & William DeWolf endowed Professor at Harvard Medical School / Chair of Research with American Urological Association

Join to view full profile

330 Brookline Ave. Rabb 440Boston, MA 02215
Phone+1 617-667-4705

Dr. Olumi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Olumi's full profile Already have an account?

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 1998 - 2000
UCSF HealthMolecular Medicine, 1995 - 1998
Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 1994 - 1995
Mass General Brigham/Brigham and Women's HospitalResidency, Surgery, 1992 - 1994
Keck School of Medicine of the University of Southern CaliforniaClass of 1992

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1995 - Present
MA State Medical License 1993 - 2028
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017

Clinical Trials

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy Start of enrollment: 2020 Sep 25
RECRUITING
NA

Publications & Presentations

PubMed

Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder.
Phillip Kim, Sumedh Kaul, Aaron Fleishman, Agustin Perez-Londono, Simon Kim
Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada. 2026-07-20
Diabetes Is an Independent Risk Factor for Radiation-Induced Hematuria After Robotic Stereotactic Body Radiotherapy for Prostate Cancer.
Lucia Elting, Jamil Almohtasib, Ignacio F San Francisco, Agustín Pérez-Londoño, Ra'ad Al-Faouri
International Journal of Urology. 2026-07-01
Association of Patient, Disease, and Socioeconomic Characteristics With Receipt of Intravesical Bacillus Calmette-Guérin Therapy From 2002-2017 and the Impact of BCG S...
David Kennedy-Yoon, Jamil Almohtasib, Sumedh Kaul, Aaron Fleishman, Peter Chang
Urology. 2026-07-01

Authored Content

Zonal Growth Pattern of the Prostate Is Affected by Age and Body Mass IndexDecember 2021

Press Mentions

Five Easy Health Tips for MenJune 18th, 2019

Grant Support

New Treatment Strategies and Epigenetic Biomarker for Management of BPHBETH ISRAEL DEACONESS MEDICAL CENTER2024–2029
Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell SurvivalBETH ISRAEL DEACONESS MEDICAL CENTER2024–2028
SRD5A2 as a Marker of Resistance to 5ARI TherapyBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
Stromal-Epithelial Interactions In Development Of BPHNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
Stromal-Epithelial Interactions In Development Of BPHNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006